AlphAIalphai — Financial news for AI agents
yahoo.comSEP 42 min read$FIVE

Five Below Shares Rise After Q2 Earnings Beat and Guidance Increase

Five Below (FIVE) shares rose 6.2% premarket after Q2 earnings beat estimates ($1.68 EPS vs. $1.33) and net sales grew 22.9% YoY to $1.26B. Comparable sales increased 14.1%. The company raised FY2026 guidance for net sales ($5.63B-$5.71B) and EPS ($9.83-$10.31). Analysts updated price targets (DB: $334, JEF: $350).

Original reporting
yahoo.com
Published Sep 4, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Five Below Shares Rise After Q2 Earnings Beat and Guidance Increase — source image
Source · yahoo.com
Decision brief

The 30-second read

$FIVEBullishHigh
01

Why it matters

The earnings beat and guidance raise provide a fresh catalyst for traders.

02

Market read

Strong earnings and guidance lift Five Below and may lift the consumer discretionary sector.

03

What to watch

Potential supply‑chain constraints could temper future sales growth.

Relevance 8/10Novelty 8/10Timing: premarket today

Background

Five Below reported Q2 FY2026 results, beating estimates and raising guidance.

Company-level read

Ticker impact

$FIVEBullishHigh confidence
Context

Q2 earnings beat and raised FY2026 guidance; premarket price up 6.2%

Expected impact

Potential continued rally toward upper range of 52‑week high.

Evidence & confidence

EPS beat, 22.9% sales growth, and new $600M buyback provide clear catalyst.

Market effects

Sector

Specialty retail sector may see broader optimism from Five Below's results.

Regional

U.S. consumer discretionary stocks could benefit.

Global

Limited to U.S. markets.

Counterpoint

What could challenge this read

Higher guidance may already be priced in; risk of overextension.

Key entities

  • Company
    Five Below

    Specialty value retailer (NASDAQ:FIVE).

Read at source← All news

Also covered by

1 outlet

Related articles

SEP 4
$FIVEMedAI 8/10

Five Below Q2 Earnings Call Highlights

Five Below (FIVE) opened 52 net new stores in Q2, ending with 2,022 locations. Adjusted gross profit rose 31% to $449M, and adjusted operating income more than doubled to $113M. The company raised its full-year sales outlook to $5.63B-$5.71B and expects Q3 sales of $1.21B-$1.23B. It plans to invest in store experience and digital capabilities using tariff refunds.

yahoo.com3 min
SEP 3
$FIVEHighAI 8/10

Cramer says buy this retail stock after the market got its latest quarter all wrong

Jim Cramer of CNBC's 'Mad Money' argued that Five Below's stock is undervalued after its latest quarterly results, despite a market downturn. The retailer beat expectations with 14.1% comparable sales growth and raised its full-year guidance. Cramer attributed the market's reaction to concerns about decelerating growth and higher oil prices, but he highlighted CEO Winnie Park's successful turnaround strategy. Five Below's new earnings forecast implies over 50% growth, making the stock attractive

cnbc.com2 min
SEP 3
$SNOWMed

Stocks making the biggest moves premarket: Snowflake, Moderna, Broadcom & more

Snowflake shares surged 24% after Q2 results beat estimates, with revenue of $1.55B and EPS of $0.62. Broadcom fell 2.5% on lower Q4 revenue forecasts. Campbell's dropped 7% on weak fiscal 2027 guidance. Ultragenyx plunged 46% after a failed drug trial. Petco rose 9% on strong Q2 margins. Moderna declined 2% after a downgrade. Argan gained 7.5% on better-than-expected earnings. Five Below rose 4.5% on strong Q2 results. Victoria's Secret fell 18% on missed revenue estimates. Netskope rose 12% on

cnbc.com3 min
Five Below Shares Rise After Q2 Earnings Beat and Guidance Increase — alphai